首页> 外国专利> Highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof

Highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof

机译:难溶性药物的高效长效缓释制剂及其制备方法

摘要

A high-efficacy, long-acting, slow-release formulation of the poorly soluble drug, comprising solid dispersion of the poorly soluble drug, silica nanoparticles loaded with the poorly soluble drug, matrix material, and release enhancer, wherein the mass ratio of these components is solid dispersion of the poorly soluble drug: silica nanoparticles loaded with the poorly soluble drug: matrix material: release enhancer=1: 0.5˜1.25: 0.1˜0.3: 0.1˜0.3; the said solid dispersion of the poorly soluble drug contains povidone K30, soybean lecithin, and acrylic resin IV, wherein the mass ratio of the drug and the accessory materials is poorly soluble drug: povidone K30: soybean lecithin: acrylic resin IV=1: 1˜3: 0.3˜0.8: 0.2˜0.5. Compared with the existing formulations, the in vivo half life of the high-efficacy, long-acting formulation of the poorly soluble drug disclosed in this invention is 2.3˜14.8 times longer while the mean residence time (MRT) of which is 7.94˜4.52 times longer; when tested in vivo in Beagle dogs, this new formulation of the poorly soluble drug presents a smoother concentration-time curve and reaches a continuous release for 72 hours. This invention discloses its preparation method.
机译:一种难溶性药物的高效,长效,缓释制剂,包括难溶性药物的固体分散体,负载有难溶性药物的二氧化硅纳米颗粒,基质材料和释放促进剂,其中这些物质的质量比组分为难溶性药物:负载有难溶性药物:基质材料的二氧化硅纳米颗粒的固体分散体:释放促进剂= 1:0.5〜1.25:0.1〜0.3:0.1〜0.3;所述难溶性药物的固体分散体包含聚维酮K30,大豆卵磷脂和丙烯酸树脂IV,其中,药物与辅助材料的质量比为难溶性药物:聚维酮K30:大豆卵磷脂:丙烯酸树脂IV = 1:1 〜3:0.3〜0.8:0.2〜0.5。与现有制剂相比,本发明公开的难溶性药物的高效长效制剂的体内半衰期长2.3〜14.8倍,而其平均停留时间(MRT)为7.94〜4.52。更长的时间当在Beagle犬体内进行测试时,这种难溶性药物的新配方呈现出更平滑的浓度-时间曲线,并连续释放72小时。本发明公开了其制备方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号